why choose us

First received: May 04, 2023

Clinical Trial: Advanced Cardiovascular Imaging of the Systemic Effects of Inflammasome Activation

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Myocardial Infarction

Study Type: INTERVENTIONAL


Official Title: Advanced Cardiovascular Imaging of the Systemic Effects of Inflammasome Activation

Brief Summary: Subjects with urgently reperfused type I myocardial infarction (MI) will be recruited and randomized to receive either placebo or the oral inflammasome (NLRP3) inhibitor dapansutrile.The primarily outcome measure will be carotid plaque volume change over 6 months; secondary outcome measures will be plaque inflammatory activity and coronary microvascular function.

Read more